课题基金 / 基金详情

Structure and function of a imprinting center in the region of human SNRPN gene

Structure and function of a imprinting center in the region of human SNRPN gene
人类SNRPN基因印记中心的结构和功能
批准号:
09672312
负责人:
NAKAO Mitsuyoshi
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

NAKAO Mitsuyoshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Certain mammalian genes are expressed exclusively from either the paternal and the maternal chromosome because of a differential marking process that occurs during gametogenesis. This epigenetic marking is called genomic imprinting. I focused on an imprinted SNRPN gene region in the Prader-Willi/Angelman syndrome. Our data revealed the correlations between the differential SNRPN gene activity and the changes in DNA methylation, higher order chromatin structure and replication timing. Further, we isolated and characterized a new member of the methyl-CpG binding proteins, named PCM1 (MBD1), which possesses a methyl-CpG binding domain and cysteine-rich CXXC regions. Four PCM1 isoforms were newly identified to be alternatively spliced in the CXXC domains and the C-terminus. All forms of PCM1 inhibited the promoter activity of SNRPN gene via methylation. Interestingly, three copies of the CXXC domain in the PCM1 isoforms enhanced the suppressive effect on the transcription from both methylated and unmethylated SNRPN promoters. In contrast, PCM1 isoforms containing two copies of the CXXC domain inhibited methylated but not unmethylated promoter, suggesting that the CXXC domain is a regulatory element of PCMI.These findings suggested that methyl-CpG binding proteins play important roles in methylation-mediated transcriptional silencing of SNRPN gene.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Y.Nagata,et al.: "The stabilization mechanism of mutant-type p53 by impaired ubiquitination:the loss of wild-type p53 function and the hsp90 association." Oncogene. (in press). (1999)
Y.Nagata 等人:“泛素化受损导致突变型 p53 的稳定机制:野生型 p53 功能和 hsp90 关联的丧失。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M.Nakao,et al.: "Emerging Therapeutic Targets(Ashley Publications Ltd.)" Emerging Therapeutic Targets in Meningiomas and Schwannomas : The Neurofibromatosis type 2 protein(Merlin).(in press), (1999)
M.Nakao 等人:“新兴治疗靶点(Ashley Publications Ltd.)”脑膜瘤和神经鞘瘤的新兴治疗靶点:神经纤维瘤病 2 型蛋白(Merlin)。(出版中),(1999 年)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
33
    Application of estrogen induced apoptosis in endocrine therapy-resistant breast cancer using Eleanor RNAs as an indicator
    • 批准号:
      18K19479
    • 项目类别:
      Grant-in-Aid for Challenging Research (Exploratory)
    • 资助金额:
      $3.99万
    • 财政年份:
      2018
    • 负责人:
      NAKAO Mitsuyoshi
    • 依托单位:
    Anti-aging effect of lysine demethylase inhibition and its biomedical application
    • 批准号:
      24659152
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2012
    • 负责人:
      NAKAO Mitsuyoshi
    • 依托单位:
    Cellular energy control by lysine demethylation and its therapeutic potentials
    • 批准号:
      23659173
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.58万
    • 财政年份:
      2011
    • 负责人:
      NAKAO Mitsuyoshi
    • 依托单位:
    Multifunction of chromatin insulator and epigenetic regulation
    • 批准号:
      22390055
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.9万
    • 财政年份:
      2010
    • 负责人:
      NAKAO Mitsuyoshi
    • 依托单位:
    海外基金